Development Manufacturing and Commercialization Sample Clauses
The DEVELOPMENT, MANUFACTURING AND COMMERCIALIZATION clause defines the parties' respective rights and obligations regarding the creation, production, and sale of a product or technology covered by the agreement. It typically outlines which party is responsible for research and development activities, who will handle manufacturing processes, and how commercialization efforts such as marketing, distribution, and sales will be managed. This clause ensures that each stage of bringing a product to market is clearly assigned, reducing ambiguity and helping to prevent disputes over responsibilities and revenue sharing.
Development Manufacturing and Commercialization. Epirus shall be solely responsible, at its sole cost and expense, for all Development, Manufacturing and Commercialization activities with respect to the Licensed Technology and Products in the Territory and the Field.
Development Manufacturing and Commercialization. (a) Subject to the terms and conditions of this Agreement (including those activities to be performed by Xencor during the Research Term), Amgen (itself and with its Affiliates and Sublicensees, as applicable) shall be responsible, at its sole cost and expense, for all development, regulatory, manufacturing and commercialization activities with respect to each Product in the Field in the Territory, including distribution, marketing and sales activities. For clarity, after the completion of the Research Term, Amgen shall continue to have the right to conduct preclinical development with respect to all Products (but shall not have the right to create new Compounds). Subject to the terms and conditions of this Agreement, all decisions concerning the development, marketing and sales of Products, including the clinical and regulatory strategy, design, sale, price and promotion of Products shall be within the sole discretion of Amgen.
(b) On a Program-by-Program basis, Amgen shall use Commercially Reasonable Efforts (itself and with its Affiliates and Sublicensees, as applicable) to develop, obtain and maintain Regulatory Approval of, and, if successful, commercialize a Product from each Program on a worldwide basis.
Development Manufacturing and Commercialization. 5.1 Development, Manufacture, and Commercialization of Licensed Products. Kite shall use Commercially Reasonable Efforts to Develop and Commercialize at least [****] Licensed Product in the Kite Field in the U.S. Kite shall have sole control and responsibility for the Manufacture, directly or with or through Third Parties, of Kite’s requirements of the Licensed Products. As between the Parties, Kite shall bear all costs and expenses associated with activities performed by Kite. Alpine may notify Kite in writing if Alpine in good faith believes that Kite is not meeting its diligence obligations set forth in this Section 5.1, and the Parties shall meet and discuss the matter in good faith. Alpine may further request review of Kite’s records generated and maintained as required under Section 5.2.
Development Manufacturing and Commercialization. Following the Research Program Term, Merck (and its Affiliates), either itself or with Third Party(ies), shall have the sole right to (and shall control all aspects of) research, develop (including pre-clinical and clinical development), manufacture, register and commercialize (including marketing, promoting, selling, distributing and determining pricing) Product Candidates and Licensed Products. All development and commercialization efforts with respect to the Product Candidates and Licensed Products shall be at the discretion of Merck, subject to the terms of this Agreement, including Section 2.14 and Section 3.8.
Development Manufacturing and Commercialization. 1Overview. If ArriVent exercises the Option for the Collaboration Program, ArriVent will have the exclusive right and sole responsibility and decision-making authority, at its sole cost and expense, to Research, Develop, Manufacture and Commercialize any applicable Compound and Product in the Field in the Territory, in each case, by itself or through one or more Affiliates, Sublicensees or other Third Parties.
Development Manufacturing and Commercialization. Merck (and its Affiliates), either itself or with Third Party(ies) shall have the sole right (and shall control all aspects of), at its own expense, to develop and commercialize Products, and for clarity, Bionomics (and its Affiliates) shall have no right to do so (except that Bionomics shall perform the activities to be performed by Bionomics under the Research Program in accordance with this Agreement). Merck (and its Affiliates), either itself or with Third Party(ies) shall use its Commercially Reasonable Efforts to develop, file for Marketing Authorization for and, following receipt of all applicable Marketing Authorizations, to commercialize [***], and all other development and commercialization efforts and decisions with respect to the Compounds and Products shall be at the discretion of Merck. Merck (and its Affiliates) either itself or with Third Party(ies) shall have the sole right (and shall control all aspects of), at its own expense, to manufacture Compound and Product, and Bionomics (and its Affiliates) shall have no right to do so (except that Bionomics shall perform the activities to be performed by Bionomics under the Research Program in accordance with this Agreement).
Development Manufacturing and Commercialization. MACROBUTTON DocID \\4126-6252-2948 v34
Development Manufacturing and Commercialization. Regeneron shall have the right to grant one or more sublicenses under the licenses granted to Regeneron under Section 4.1, in full or in part, by means of written agreement to Affiliates or Third Parties (with the right to sublicense through multiple tiers), without the prior written consent of CytomX, for the performance of Regeneron’s Development, Manufacturing and Commercialization activities related to Licensed Products or for the performance of any other activities related to the Exploitation of a Licensed Product. As a condition precedent to and requirement of any such sublicense: (a) Regeneron shall furnish a redacted copy of such sublicense agreement to CytomX; (b) any such permitted sublicense shall be consistent with and subject to the terms and conditions of this Agreement (including for the avoidance of doubt, that if sales by such Sublicensee are included in Net Sales hereunder, such Sublicensee shall permit audit rights with respect to its reporting of Net Sales that are consistent with those given by Regeneron hereunder with respect to its sales included in Net Sales); (c) Regeneron will continue to be responsible for full performance of its obligations under this Agreement and will be responsible for all actions of such Sublicensee as if such Sublicensee were Regeneron hereunder; and (d) ▇▇▇▇▇▇▇▇▇’s grant of any sublicense will not relieve Regeneron or its Affiliates from any of its obligations under this Agreement.
Development Manufacturing and Commercialization. 3.1 For a period of forty-eight (48) months after the Effective Date, Avenue shall not, either directly by itself or indirectly through any Subsidiary, Sublicensee or Third Party, Develop, Commercialize, Manufacture, use, sell, offer for sale, import or export any Competing Product in the Field in any part of the Territory.
3.2 As of the Effective Date, Licensor will have sole control over Development, Manufacturing and Commercialization of Licensor Product and have the right to terminate foregoing activities for any reason in its sole discretion. Avenue will have no recourse against Licensor for failure to achieve any Milestone Event.
Development Manufacturing and Commercialization